A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis-A Pilot Study

Int J Mol Sci. 2024 Dec 5;25(23):13067. doi: 10.3390/ijms252313067.

Abstract

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common chronic liver disorder in Western countries, encompassing a range of conditions from steatosis to Metabolic Dysfunction-Associated Steatohepatitis (MASH), which can potentially progress to cirrhosis. Lipidomics approaches have revealed significant alterations in the hepatic lipidome associated with both steatosis and steatohepatitis, with these changes correlating with disease manifestation. While the transition from steatosis to MASH remains poorly understood, recent research indicates that both the quantity and quality of deposited lipids play a pivotal role in MASLD progression. In our study, we utilized untargeted and targeted analyses to identify intact lipids and fatty acids in liver biopsies from healthy controls and MASLD patients, categorized based on their histological findings. In total, 447 lipid species were identified, with 215 subjected to further statistical analysis. Univariate and multivariate analyses revealed alterations in triglyceride species and fatty acids, including FA 16:0, FA 16:1, FA 18:3 n6, the sum of MUFA, and the Δ9-desaturase activity ratio. This research provides insights into the connection between dysregulated lipid metabolism in the progression of MASLD, supporting previous findings. Further studies on lipid metabolism could improve risk assessment methods, particularly given the current limited understanding of the transition from steatosis to MASH.

Keywords: Metabolic Dysfunction-Associated Steatohepatitis; Metabolic Dysfunction-Associated Steatotic Liver Disease; fatty acid profile; liver biopsies; untargeted lipidomics analysis.

MeSH terms

  • Adult
  • Aged
  • Fatty Acids / metabolism
  • Fatty Liver / metabolism
  • Fatty Liver / pathology
  • Female
  • Humans
  • Lipid Metabolism*
  • Lipidomics* / methods
  • Lipids / analysis
  • Liver* / metabolism
  • Liver* / pathology
  • Male
  • Middle Aged
  • Pilot Projects
  • Triglycerides / metabolism

Substances

  • Fatty Acids
  • Triglycerides
  • Lipids

Grants and funding

This research received no external funding.